Претраживање
Приказ резултата 1-7 од 7
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
(Sharjah: Bentham Science Publishers, 2015)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
(Sharjah: Bentham Science Publishers, 2019)
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
(European Journal of Pharmaceutical Sciences, 2017)
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
(European Journal of Pharmaceutical Sciences, 2019)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.
(Current Medicinal Chemistry, 2019)